Featured Research

from universities, journals, and other organizations

African-Americans respond better to rubella vaccine, study shows

Date:
February 26, 2014
Source:
Mayo Clinic
Summary:
Somali Americans develop twice the antibody response to rubella from the current vaccine compared to Caucasians in a new study on individualized aspects of immune response. A non-Somali, African-American cohort ranked next in immune response, still significantly higher than Caucasians, and Hispanic Americans in the study were least responsive to the vaccine.

Somali Americans develop twice the antibody response to rubella from the current vaccine compared to Caucasians in a new Mayo Clinic study on individualized aspects of immune response. A non-Somali, African-American cohort ranked next in immune response, still significantly higher than Caucasians, and Hispanic Americans in the study were least responsive to the vaccine. The findings appear in the journal Vaccine.

"This is fascinating," says Gregory Poland, M.D., Mayo Clinic vaccinologist and senior author of the study. "We don't know why these groups reacted so differently to the vaccine -- that's a subject for further studies -- but this new information will help us as we design the vaccines of the future. It will ultimately change how we practice medicine."

The researchers studied a sample of 1,100 healthy children and young adults in Rochester, as well as over 1,000 participants from the U.S. Naval Health Research Center in San Diego as the control group. The Navy members, aged 18 to 40, were all healthy and recently vaccinated, and represented a cross-section of ethnic groups. The study also looked at a subset of a recent immigrant population from Somalia in Rochester. The Minnesota case studies were done in cooperation with the Rochester Epidemiology Project.

The researchers hypothesized that race, sex or ethnicity might contribute to differences in immune response. They found no difference in gender -- a surprise, says Dr. Poland, because in most studies women consistently have a better immune response to vaccines than men.

"The significance of the findings is that in the future we may be able to create vaccines for specific groups or even individuals based on their genomic and other characteristics," says Dr. Poland. "That may mean adjusting doses for some or being able to treat larger populations with the same vaccine if the dosage is less."


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Journal Reference:

  1. Iana H. Haralambieva, Hannah M. Salk, Nathaniel D. Lambert, Inna G. Ovsyannikova, Richard B. Kennedy, Nathaniel D. Warner, V.Shane Pankratz, Gregory A. Poland. Associations between race, sex and immune response variations to rubella vaccination in two independent cohorts. Vaccine, 2014; DOI: 10.1016/j.vaccine.2014.01.090

Cite This Page:

Mayo Clinic. "African-Americans respond better to rubella vaccine, study shows." ScienceDaily. ScienceDaily, 26 February 2014. <www.sciencedaily.com/releases/2014/02/140226155505.htm>.
Mayo Clinic. (2014, February 26). African-Americans respond better to rubella vaccine, study shows. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/02/140226155505.htm
Mayo Clinic. "African-Americans respond better to rubella vaccine, study shows." ScienceDaily. www.sciencedaily.com/releases/2014/02/140226155505.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins